Skin wound closure in athymic mice with cultured human cells, biopolymers, and growth factors.
Skin wound closure remains a major problem in acute and reconstructive skin grafting after large burns because of limited availability of donor skin. This report evaluates six protocols for preparation in vitro of skin substitutes composed of cultured human cells, biopolymers, and growth factors for wound closure. Full-thickness wounds in athymic mice treated in a single procedure with cultured skin substitutes were compared directly to treatments with murine skin autograft, human skin xenograft, or no graft. Rectilinear planimetry of healed wounds 6 weeks after surgery showed that skin substitutes cultured in serum-free medium, and for 24 hours before surgery in defined medium with basic fibroblast growth factor (100 ng/ml), were not statistically different (p less than 0.05) in size from treatment with human skin xenograft. Acceptance and persistence of skin substitutes cultured in serum-free media were 70% at 6 weeks after surgery, as determined by staining of healed skin with a fluorescein-labeled monoclonal antibody against human HLA-ABC antigens. Ultrastructural examination of wounds with cultured human skin 6 weeks after treatment showed complete basement membrane, including anchoring fibrils, presence of melanocytes and pigment transfer to keratinocytes, and innervation of healed skin adjacent to basement membrane. These findings demonstrate effectiveness of cultured skin substitutes for closure of skin wounds and illustrate important capabilities to modulate the natural processes of wound repair, to increase supply of materials used for wound repair, and to enhance quality of wound healing.
Boyce
S T
ST
Department of Surgery, University of California, San Diego.
Foreman
T J
TJ
English
K B
KB
Stayner
N
N
Cooper
M L
ML
Sakabu
S
S
Hansbrough
J F
JF
D000818:Animals; D001704:Biopolymers; D002478:Cells, Cultured; D016895:Culture Media, Serum-Free; D016222:Fibroblast Growth Factor 2; D005455:Fluorescent Antibody Technique; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D012038:Regeneration; D012867:Skin / Q000166:cytology* / Q000648:ultrastructure; D012871:Skin Diseases / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D016038:Skin Transplantation; D014182:Transplantation, Autologous; D014183:Transplantation, Heterologous; D014945:Wound Healing; D014947:Wounds and Injuries / Q000473:pathology / Q000601:surgery / Q000628:therapy*
D001704:Biopolymers; D016895:Culture Media, Serum-Free; D006680:HLA Antigens; D016222:Fibroblast Growth Factor 2